Talking Techniques | Hans Keirstead on precision therapeutics for cancer and science in politics
Hans Keirstead, CEO and Founder of Aivita Biomedical, speaks to Tristan Free, Digital Editor of BioTechniques. Hans delves into his company’s exciting new precision immunotherapy, currently undergoing phase II trials, and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.
If you were interested by this podcast and the precision therapeutics discussed, check out our upcoming BioTechniques Online Event: Advancing Precision Medicine 2019 and register for free today
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
